NEWS
FOCUS
FOCUS 01.20 – VITROSCREEN – SENZAGEN PARTNERSHIP
Since December 2019, VitroScreen is a distributor of SenzaGen’s GARD test platform which includes [...]
FOCUS 02 19 – VITROSCREEN AWARDED FOCUS THE BEST POSTER IFSCC 2019
The International Organizing Commitee has awarded as best poster of IFSCC 2019 VitroScreen’s poster [...]
FOCUS 01 19 – SEMINARIO VITROSCREEN BIOCOMPATIBILITA’ DI DM
L’evoluzione dello Standard ISO 10993 implica l’adeguamento del percorso di valutazione della biocompatibilità dei [...]
FOCUS 03 18 – VITROSCREEN EXPERTISE ON HOST RESPONSE
VitroScreen microbiome research platform is based on human tissue models colonized with bacteria and [...]
FOCUS 02 18 – VITROSCREEN EXPERTISE ON MICROBIOME
Commitment to provide scientific evidence to new generation products Vitroscreen within its mission [...]
FOCUS 01 18 – NEW HISTO-MORPHOLOGY PLATFORM
A new integrate platform Today Vitroscreen provides its customers with an improved integrate [...]
FOCUS 02 17 – INVESTING IN IN VITRO SCIENCE
Vitroscreen Mission It encompasses not only up-to-date in vitro models and testing services [...]
FOCUS 01 17 – MEDICAL DEVICES
Towards the New Medical Device Regulation (MDR) The MDR is making its [...]
FOCUS 02 16 – REACH UPDATE
VitroScreen expertise on GLP compliant in vitro testing strategies REACH requirements for [...]
FOCUS 01 16 – SYMPOSIUM ON MUCOSAL IMMUNITY
On Thursday May 19th, VitroScreen organized an international Symposium to celebrate its 15 years [...]
FOCUS 02 15 – SKIN SENSITIZATION
SKIN SENSITIZATION EXPERTISE VitroScreen has implemented in compliance with GLP the replacement [...]
FOCUS 01 15 – EU-NETVAL
VitroScreen has implemented STE assay (OECD TG 491) in compliance to GLP. [...]
FOCUS 02 14 – EU-NETVAL
VitroScreen has been appointed as a member of EU-NETVAL On the 10th [...]
FOCUS 01 14 – E.COLI INVASION MODEL
ESCHERICHIA COLI INVASION MODEL on Caco-Goblet® cells The bacterial’s adhesion to the [...]